NICOLE NOLAN: Open Payments
NPI 1548786205 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 30 payments from 7 companies in 2025. Trend: 2023 $636 · 2024 $642 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $392 |
| Amgen Inc. | 10 | $290 |
| Novo Nordisk Inc | 4 | $101 |
| Lilly USA, LLC | 4 | $66 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, KRYSTEXXA, QULIPTA, OTEZLA, Ozempic, MOUNJARO, REPATHA, Wegovy.
Industry payments across MI — which companies pay providers there.
